Targeting HSP90 with the Small Molecule Inhibitor AUY922 (luminespib) as a Treatment Strategy Against Hepatocellular Carcinoma

Thumbnail
View/ Open

Show full item record
Author
McCubrey, James A.
URI
http://hdl.handle.net/10342/9597
Subject
 HSP90; Sorafenib; Hepatocellular carcinoma (HCC) 
Date
2019-05-15
Citation:
APA:
McCubrey, James A.. (May 2019). Targeting HSP90 with the Small Molecule Inhibitor AUY922 (luminespib) as a Treatment Strategy Against Hepatocellular Carcinoma. International Journal of Cancer, (144:10), p.2613-2624. Retrieved from http://hdl.handle.net/10342/9597

Display/Hide MLA, Chicago and APA citation formats.

MLA:
McCubrey, James A.. "Targeting HSP90 with the Small Molecule Inhibitor AUY922 (luminespib) as a Treatment Strategy Against Hepatocellular Carcinoma". International Journal of Cancer. 144:10. (2613-2624.), May 2019. May 25, 2022. http://hdl.handle.net/10342/9597.
Chicago:
McCubrey, James A., "Targeting HSP90 with the Small Molecule Inhibitor AUY922 (luminespib) as a Treatment Strategy Against Hepatocellular Carcinoma," International Journal of Cancer 144, no. 10 (May 2019), http://hdl.handle.net/10342/9597 (accessed May 25, 2022).
AMA:
McCubrey, James A.. Targeting HSP90 with the Small Molecule Inhibitor AUY922 (luminespib) as a Treatment Strategy Against Hepatocellular Carcinoma. International Journal of Cancer. May 2019; 144(10) 2613-2624. http://hdl.handle.net/10342/9597. Accessed May 25, 2022.
Collections